Bank of New York Mellon’s Eton Pharmaceutcials ETON Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.81M | Buy |
127,344
+53,098
| +72% | +$757K | ﹤0.01% | 2789 |
|
2025
Q1 | $964K | Hold |
74,246
| – | – | ﹤0.01% | 3081 |
|
2024
Q4 | $989K | Sell |
74,246
-245
| -0.3% | -$3.26K | ﹤0.01% | 3155 |
|
2024
Q3 | $447K | Hold |
74,491
| – | – | ﹤0.01% | 3575 |
|
2024
Q2 | $245K | Hold |
74,491
| – | – | ﹤0.01% | 3886 |
|
2024
Q1 | $279K | Sell |
74,491
-4,911
| -6% | -$18.4K | ﹤0.01% | 3798 |
|
2023
Q4 | $348K | Hold |
79,402
| – | – | ﹤0.01% | 3733 |
|
2023
Q3 | $331K | Hold |
79,402
| – | – | ﹤0.01% | 3758 |
|
2023
Q2 | $277K | Hold |
79,402
| – | – | ﹤0.01% | 3862 |
|
2023
Q1 | $306K | Buy |
79,402
+530
| +0.7% | +$2.04K | ﹤0.01% | 3730 |
|
2022
Q4 | $222K | Hold |
78,872
| – | – | ﹤0.01% | 3926 |
|
2022
Q3 | $165K | Hold |
78,872
| – | – | ﹤0.01% | 4086 |
|
2022
Q2 | $207K | Sell |
78,872
-583
| -0.7% | -$1.53K | ﹤0.01% | 4042 |
|
2022
Q1 | $346K | Hold |
79,455
| – | – | ﹤0.01% | 3929 |
|
2021
Q4 | $341K | Sell |
79,455
-270
| -0.3% | -$1.16K | ﹤0.01% | 4029 |
|
2021
Q3 | $401K | Buy |
79,725
+66,450
| +501% | +$334K | ﹤0.01% | 3921 |
|
2021
Q2 | $82K | Sell |
13,275
-32,112
| -71% | -$198K | ﹤0.01% | 4245 |
|
2021
Q1 | $332K | Sell |
45,387
-260
| -0.6% | -$1.9K | ﹤0.01% | 3861 |
|
2020
Q4 | $371K | Buy |
45,647
+11,778
| +35% | +$95.7K | ﹤0.01% | 3747 |
|
2020
Q3 | $268K | Buy |
33,869
+315
| +0.9% | +$2.49K | ﹤0.01% | 3757 |
|
2020
Q2 | $182K | Buy |
+33,554
| New | +$182K | ﹤0.01% | 3811 |
|